These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33464392)

  • 21. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
    van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
    Rheumatology (Oxford); 2008 Oct; 47(10):1571-6. PubMed ID: 18710900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up.
    Poppelaars PBM; van Tuyl LHD; Boers M
    Ann Rheum Dis; 2019 May; 78(5):586-589. PubMed ID: 30808623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis.
    Kume K; Amano K; Yamada S; Kanazawa T; Ohta H; Hatta K; Amano K; Kuwaba N
    Rheumatology (Oxford); 2014 May; 53(5):900-3. PubMed ID: 24441151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
    Landewé R; Geusens P; Boers M; van der Heijde D; Lems W; te Koppele J; van der Linden S; Garnero P
    Arthritis Rheum; 2004 May; 50(5):1390-9. PubMed ID: 15146408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.
    Krieckaert CL; Nurmohamed MT; Wolbink G; Lems WF
    Rheumatology (Oxford); 2013 Mar; 52(3):547-53. PubMed ID: 23221326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of low dose methotrexate on bone density.
    Cranney AB; McKendry RJ; Wells GA; Ooi DS; Kanigsberg ND; Kraag GR; Smith CD
    J Rheumatol; 2001 Nov; 28(11):2395-9. PubMed ID: 11708409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study.
    Haugeberg G; Conaghan PG; Quinn M; Emery P
    Ann Rheum Dis; 2009 Dec; 68(12):1898-901. PubMed ID: 19386610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T
    Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study.
    Engvall IL; Svensson B; Tengstrand B; Brismar K; Hafström I;
    Arthritis Res Ther; 2008; 10(6):R128. PubMed ID: 18986531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids.
    Habib GS; Haj S
    Clin Rheumatol; 2005 Apr; 24(2):129-33. PubMed ID: 15372317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U; Teichmann J; Müller-Ladner U; Strunk J
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab.
    Marotte H; Pallot-Prades B; Grange L; Gaudin P; Alexandre C; Miossec P
    Arthritis Res Ther; 2007; 9(3):R61. PubMed ID: 17597527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination DMARD therapy including corticosteroids in early rheumatoid arthritis.
    Möttönen TT; Hannonen PJ; Boers M
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S59-65. PubMed ID: 10589359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis.
    Güler-Yüksel M; Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Groenendael JH; Mallée C; de Bois MH; Breedveld FC; Dijkmans BA; Lems WF
    Ann Rheum Dis; 2009 Mar; 68(3):330-6. PubMed ID: 18375540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids.
    Yilmaz L; Ozoran K; Gündüz OH; Uçan H; Yücel M
    Rheumatol Int; 2001 Feb; 20(2):65-9. PubMed ID: 11269535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.
    van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
    J Rheumatol; 2009 Jul; 36(7):1380-6. PubMed ID: 19487259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.
    Garnero P; Landewé R; Boers M; Verhoeven A; Van Der Linden S; Christgau S; Van Der Heijde D; Boonen A; Geusens P
    Arthritis Rheum; 2002 Nov; 46(11):2847-56. PubMed ID: 12428224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C; Karlsson M; Akesson K; Jacobsson L
    Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.